@article{oai:kanazawa-u.repo.nii.ac.jp:00014418,
 author = {Kometani, Mitsuhiro and Yoneda, Takashi and Demura, Masashi and Karashima, Shigehiro and Mori, Shunsuke and Oe, Masashi and Sawamura, Toshitaka and Okuda, Rika and Yamagishi, Masakazu and Takeda, Yoshiyu},
 issue = {7},
 journal = {Internal Medicine},
 month = {Apr},
 note = {Primary aldosteronism (PA) is a major cause of secondary hypertension, divided into two subtypes: unilateral and bilateral. Unilateral PA (u-PA) is surgically-curable. Medical treatment with mineralocorticoid receptors antagonists is recommended as a second-line treatment when the patients are not candidate for surgical treatment. The present case was a 39-year-old woman with u-PA, who had refused surgery, had suffered from adverse effects of medical treatment. She was treated with transcatheter adrenal arterial embolization (TAAE). Her blood pressure had been well controlled without progression of cardiorenovascular damage for 12 years. TAAE can be the third treatment option for u-PA patients. © 2016 The Japanese Society of Internal Medicine.},
 pages = {769--773},
 title = {The Long-term Effect of Adrenal Arterial Embolization for Unilateral Primary Aldosteronism on Cardiorenovascular Protection, Blood Pressure, and the Endocrinological Profile.},
 volume = {55},
 year = {2016}
}